Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,157 | -13,510 | -9,318 | -6,200 | -2,966 |
| Depreciation Amortization | 155 | 170 | 51 | 22 | N/A |
| Accounts payable and accrued liabilities | 73 | 599 | 793 | 328 | 1,252 |
| Other Working Capital | 109 | 802 | 736 | 883 | 1,889 |
| Other Operating Activity | 764 | 783 | 66 | 231 | -993 |
| Operating Cash Flow | $-4,056 | $-11,156 | $-7,672 | $-4,736 | $-818 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -16,698 | N/A | N/A | N/A |
| PPE Investments | -184 | -849 | -704 | -456 | -431 |
| Other Investing Activity | 0 | -93 | -93 | -93 | 0 |
| Investing Cash Flow | $-184 | $-17,640 | $-797 | $-549 | $-431 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,652 | 4,039 | 4,055 | 1 | N/A |
| Other Financing Activity | 0 | 34,992 | 34,992 | 34,810 | 34,992 |
| Financing Cash Flow | $32,652 | $39,031 | $39,047 | $34,811 | $34,992 |
| Beginning Cash Position | 14,776 | 4,541 | 4,541 | 4,541 | 4,541 |
| End Cash Position | 43,188 | 14,776 | 35,119 | 34,067 | 38,284 |
| Net Cash Flow | $28,412 | $10,235 | $30,578 | $29,526 | $33,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,056 | -11,156 | -7,672 | -4,736 | -818 |
| Capital Expenditure | -184 | -849 | -704 | -456 | -431 |
| Free Cash Flow | -4,240 | -12,005 | -8,376 | -5,192 | -1,249 |